0001171843-22-001906.txt : 20220315 0001171843-22-001906.hdr.sgml : 20220315 20220315170147 ACCESSION NUMBER: 0001171843-22-001906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220311 FILED AS OF DATE: 20220315 DATE AS OF CHANGE: 20220315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Colleran David CENTRAL INDEX KEY: 0001646558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 22742046 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY PARK DRIVE STREET 2: SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0306 4 2022-03-11 0 0000898437 Anika Therapeutics, Inc. ANIK 0001646558 Colleran David 32 WIGGINS AVENUE BEDFORD MA 01730 0 1 0 0 EVP, General Counsel, Corp Sec Restricted Stock Unit 0.00 2022-03-11 4 A 0 22988 0 A Common Stock 22988 22988 D Stock Option (Right to Buy) 28.14 2022-03-11 4 A 0 35864 0 A 2032-03-11 Common Stock 35864 35864 D Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023. Represents a 10% premium above the closing price of Anika's common stock on the date of grant. The premium priced stock options vest in three equal annual installments beginning on March 11, 2023. /s/ David Colleran 2022-03-15